SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the return of "OG Memes" and 2021 vibes, fueled by bullish sentiment following recent market events. Community members are actively promoting its strong community, potential exchange listings, and the revival of Rage Comics, emphasizing the importance of conviction and bag-working in the current market. Discussions also focus on onboarding 1 million users to crypto via their community.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its community-driven approach and its connection to cannabis culture on the Solana blockchain. Community members are emphasizing its long-term vision, focus on positivity, and its potential within the emerging cannabis industry. Some users are drawing parallels to Bitcoin, emphasizing Weedcoin's potential for growth.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY is trending as community members rally around its strong cult following and meme-driven identity on the Solana blockchain. Despite market volatility, the community emphasizes their conviction and dedication to building a lasting presence. Discussions highlight the potential for significant growth and the unique culture surrounding $LENNY.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as it nears all-time highs, fueled by optimism around its robotaxi strategy and potential battery expansion in Europe. Community discussions revolve around the stock's valuation, potential short squeezes, and comparisons to competitors like Waymo, with some questioning the sustainability of the rally. Bullish sentiment remains strong, while bears cite concerns about sales figures and regulatory hurdles, such as California's Autopilot marketing scrutiny.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid speculation that the US cannabis sector is nearing a potential rescheduling event, possibly driven by an executive order. Community members are actively discussing the potential impact on US cannabis companies, including potential tax benefits and increased institutional investment. The ETF's price action reflects the current optimism surrounding the potential catalyst.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as investors anticipate earnings, driven by rising DRAM prices and AI-fueled demand, with analysts increasing price targets. Community members are weighing potential volatility after earnings, drawing comparisons to recent reactions to earnings from other AI-related stocks like AVGO and ORCL. Bullish sentiment surrounds MU's position as a key player in the memory sector, particularly with increasing memory prices and potential supply shortages.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors analyze its strategic shift towards weight loss drugs after recent dealmaking, with community discussions focusing on the potential valuation upside if the company successfully delivers an oral GLP-1 pill. A large short interest adds squeeze potential should positive clinical data emerge, while some traders are eyeing actionable trade alerts and call options. However, a lowered 2025 revenue outlook has tempered enthusiasm, leading to debates about management and the stock's long-term prospects.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending following positive registrational phase II study results for its CAR T therapy in stiff person syndrome, with analysts raising target prices. Community members are actively discussing the potential for a bidding war or buyout, along with the possibility of a marketed secondary offering. The surge in price and volume has traders weighing whether this is a biotech breakout or just the beginning.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the community discusses its potential role in upcoming AI infrastructure, particularly regarding power efficiency and data transfer bottlenecks. Chatter revolves around potential purchase orders and updates following a recent capital raise, with some anticipating news before the holidays.  The stock's tight coil and low float are also fueling speculation about a potential breakout.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

ARBK is trending amid discussions of a potential short squeeze and its low float, with some traders drawing comparisons to other high-flying stocks. Community members are also closely watching its relationship with Bitcoin's movements. The stock's volatility, reverse split, and restructuring are key points of conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Braidwell LP Invests $18.77 Million in Sionna Therapeutics, Inc. $SION

Braidwell LP bought a new stake in Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen

Wall Street Zen raised Sionna Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) has been given an average rating of "Moderate Buy" by the eight brokerages that are currently covering the stock, MarketBeat Ratings reports...

Sionna Therapeutics, Inc. $SION Shares Acquired by Prudential Financial Inc.

Prudential Financial Inc. increased its position in shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) by 114.6% during the second quarter, according to the company in its most recent...

Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4% - Time to Buy...

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Time to Sell...

Royal Bank Of Canada Reiterates "Underperform" Rating for Sionna Therapeutics (NASDAQ:SION)

Royal Bank Of Canada reissued an "underperform" rating and issued a $24.00 price objective on shares of Sionna Therapeutics in a research report on Monday...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.9% - Should You Sell?

Sionna Therapeutics (NASDAQ:SION) Shares Down 3.9% - What's Next...

Peter Thompson Sells 11,890 Shares of Sionna Therapeutics (NASDAQ:SION) Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 11,890 shares of the company's stock in a transaction on Tuesday, November 25th. The stock was sold at an...

Sionna Therapeutics (NASDAQ:SION) Director Sells $4,212,726.82 in Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 94,583 shares of Sionna Therapeutics stock in a transaction on Monday, November 24th. The shares were sold at an...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$42.89
Prev Close	$42.76
Open	$43.05
Dividend Yield	N/A
50-Day Moving Average	$37.62
Beta	0.95
Avg. Volume	231,740.26
PE Ratio	-26.83

52-Week High	$45.00
52-Week Low	$7.26
Market Capitalization	$1.91B
EPS (Annual)	-$1.40
Price to Book	5.93
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SION News

SIONSionna Therapeutics Inc